Inovio Shares Up After Adding Thermo Fisher as Manufacturer for Vaccine Candidate
September 09 2020 - 10:47AM
Dow Jones News
By Robb M. Stewart
Inovio Pharmaceuticals Inc. shares jumped Wednesday after the
biotechnology company signed up Thermo Fisher Scientific Inc. as
another manufacturer for its planned Covid-19 vaccine.
In morning trading, Inovio shares were up 20%, to $11.55. They
have rallied 250% year-to-date.
Inovio on Tuesday said Thermo Fisher plans to manufacture its
DNA Covid-19 vaccine candidate INO-4800, joining other contract
development and manufacturing organizations in a global
manufacturing consortium, which potentially would allow it to scale
production of a vaccine.
The company plans to have 100 million doses of INO-4800
manufactured in 2021, subject to Food and Drug Administration
approval for use as a Covid-19 vaccine. Thermo Fisher plans to
manufacture INO-4800 drug substance as well as perform
fill-and-finish of INO-4800 drug product at its commercial
facilities in the U.S. and at peak capacity could produce at least
100 million doses of INO-4800 annually, Inovio said.
Thermo Fisher will join partners Richter-Helm BioLogics and
Ology Biosciences in the manufacturing consortium, and Inovio said
it is in active discussions with additional manufacturers to join
as it prepares to meet global supply needs. Having multiple
manufacturers involved in the production of INO-4800 is intended to
support timely, cost-effective and scalable production of the
DNA-based vaccine, it said, and third-party manufacturers will
produce the patent-protected formulation for INO-4800.
Inovio is conducting a Phase 1 clinical trial of INO-4800 in the
U.S. and has submitted full trial results for the first 40 subjects
for publication in a peer-reviewed journal. The company plans to
initiate a Phase 2/3 Covid-19 vaccine trials in September, subject
to FDA clearance to proceed.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
September 09, 2020 10:32 ET (14:32 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Sep 2023 to Sep 2024